As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Merck & Co., Inc.: Readystate Asset Management LP, GTS Securities LLC, Barclays PLC, Wolverine Trading LLC, Parallax Volatility Advisers L.P., BlueCrest Capital Management Ltd, Citadel Advisors LLC, Point72 Asset Management L.P., Cubist Systematic Strategies LLC, Balyasny Asset Management L.P., Verition Fund Management LLC, Capital Fund Management S.A., PEAK6 Investments LLC, Eisler Capital US LLC, Eisler Capital UK Ltd., Goldman Sachs Group Inc., Capstone Investment Advisors LLC, Allianz Asset Management GmbH, Mendel Money Management, IMC Chicago LLC, One River Asset Management LLC, Wells Fargo & Company MN, UBS Group AG, BNP Paribas Financial Markets, Gladius Capital Management LP, Concourse Financial Group Securities Inc., CTC LLC, Genus Capital Management Inc., Simplex Trading LLC, XR Securities LLC, Wolverine Asset Management LLC, SpiderRock Advisors LLC, and Cutler Group LLC CA. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.